Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

1
Breast Cancer Therapeutics in Major Developed
Markets to 2020 - Approval of Novel Therapies to
Support Continued Dominance of HER2 Targeted Drugs
Single User License - 3500 Site User
License - 7000 Corporate User License -
10500 Publication Date - Jun 2014 Pages -
106 To know more details, email to
debora_at_reportstack.com
2
Summary

• This report provides in-depth analysis of breast
  cancer therapeutics market within the eight major
  geographies of the US, Canada, the top five
  geographies in Europe (the UK, France, Germany,
  Spain and Italy) and Japan. The report provides
  an estimation of market size for 2013, along with
  market forecast until 2020. It also covers
  disease epidemiology, treatment algorithms,
  treatment patterns, in-depth analysis of the
  pipeline, and deal analysis.
• The breast cancer therapeutics market in the
  eight major markets - The US, The UK, France,
  Germany, Spain, Italy, Japan and Canada - was
  worth 9.2 billion in 2013, and is expected to
  grow at a Compound Annual Growth Rate (CAGR) of
  5.1 to 13.1 billion by 2020. The US had the
  largest market in 2013, valued at 5.5 billion,
  equivalent to a global share of 59, followed by
  Japan with 871.5m or 9.4 and Italy with 668.5m
  or 7.2.

3
Scope
- Disease overview, as well as treatment
algorithms and treatment usage patterns- Market
size and forecast for the breast cancer market
from 2012 to 2019- Major marketed products for
breast cancer along with a heat map of product
performance- In-depth pipeline analysis for
global pipeline in breast cancer along with
clinical trial failure rate analysis- Key
drivers and restraints that have had and are
expected to have a significant impact upon the
market- Key licensing and co-development
agreements that could have impact on growth trends
4
Key Benefits
- Align your product portfolio to the markets
with high growth potential- Develop market entry
and expansion strategies by identifying the
potential regions and therapeutic segments poised
for strong growth- Devise a more effectively
tailored country strategy through the
understanding of key drivers and barriers in the
breast cancer therapeutics market- Develop key
strategic initiatives based upon an understanding
of key focus areas and leading companies-
Accelerate and strengthen your market position by
identifying key companies for mergers,
acquisitions and strategic partnerships
5
If you are interested...
Contact Debora White Email
debora_at_reportstack.com Ph1-888-789-6604 http/
/www.reportstack.com